ONMD vs PHVS

Analysts rate Pharvaris N.

V. (PHVS) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Pharvaris N.

V. (PHVS) delivered a total return of +31. 2%, compared to -90. 1% for OneMedNet Corporation (ONMD). Over 10 years, the gap is even starker: PHVS returned +2. 3% versus ONMD's -90. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), OneMedNet Corporation (ONMD) is the lower-risk stock at 0.

37β versus Pharvaris N. V. 's 1. 02β — meaning PHVS is approximately 173% more volatile than ONMD relative to the S&P 500.

On earnings-per-share growth, the picture is similar: OneMedNet Corporation grew EPS 83.

3% year-over-year, compared to 5. 7% for Pharvaris N. V.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Pharvaris N.

V. (PHVS) is the more profitable company, earning 0. 0% net margin versus -206. 1% for OneMedNet Corporation — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PHVS leads at 0. 0% versus -711. 3% for ONMD. At the gross margin level — before operating expenses — PHVS leads at 0. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, OneMedNet Corporation (ONMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

37)). Both have compounded well over 10 years (ONMD: -90. 1%, PHVS: +2. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ONMD is a small-cap high-growth stock; PHVS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.